Pfizer

News

FDA rejects Pfizer Herceptin biosimilar, wants technical inf...

A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators.

Partner Content

Partner Content

Explore New Strategies to Maintain a Global Pharmacovigilanc...

Drug Safety Conference London 2018

News

Pfizer's lung cancer drug dacomitinib gets fast US review

Drug beat AZ's Iressa in head-to-head trial, concerns over side-effects

Partner Content

Partner Content

Quick Update - Under 2 Weeks Remaining - ADC Conference

ADC Summit

News

GSK left as sole bidder for Pfizer consumer health unit

GSK is left as sole bidder amid speculation that the sale is off.

News

Pfizer eyes gastro use for Xeljanz after thumbs-up from FDA ...

Pfizer has been steadily building a franchise around its inflammatory diseases pill, Xeljanz (tofacitinib) over the last few years, and it could add another use after US experts recommended

FDA rejects Pfizer Herceptin biosimilar, wants technical inf...

Explore New Strategies to Maintain a Global Pharmacovigilanc...

Pfizer's lung cancer drug dacomitinib gets fast US review

Quick Update - Under 2 Weeks Remaining - ADC Conference

GSK left as sole bidder for Pfizer consumer health unit

Pfizer eyes gastro use for Xeljanz after thumbs-up from FDA ...

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

Pfizer

Editor's Picks